Hepatitis B and C virus resistance to antiviral therapies--EASL-AASLD-APASL-ALEH-IASL conference.
Buti
Maria
M
Hospital Vall d'Hebron/CIBER-EHD, Liver Unit, Paseo Valle de Hebron 119, Barcelona 0803, Spain. mbuti@vhebron.net
D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004279:DNA, Viral / Q000187:drug effects / Q000235:genetics; D004353:Drug Evaluation, Preclinical; D024882:Drug Resistance, Viral / Q000235:genetics; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology; D016174:Hepacivirus / Q000187:drug effects* / Q000235:genetics; D006509:Hepatitis B / Q000188:drug therapy / Q000821:virology; D006515:Hepatitis B virus / Q000187:drug effects* / Q000235:genetics; D006526:Hepatitis C / Q000188:drug therapy / Q000821:virology; D006801:Humans
D000998:Antiviral Agents; D004279:DNA, Viral